Adducin in tumorigenesis and metastasis

Cong Luo; Jiayu Shen

doi:10.18632/oncotarget.17173

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Adducin in tumorigenesis and metastasis

Cong Luo _ and Jiayu Shen

PDF | HTML | How to cite

Oncotarget. 2017; 8:48453-48459. https://doi.org/10.18632/oncotarget.17173

Metrics: PDF 1797 views | HTML 3777 views | ?

Abstract

Cong Luo1 and Jiayu Shen2

1Zhejiang Cancer Hospital, Department of Abdominal oncology, Hangzhou, Zhejiang, China

2Zhejiang Chinese Medical University, The Second Clinical Medical College, Hangzhou, Zhejiang, China

Correspondence to:

Cong Luo, email: [email protected]

Keywords: adducin, phosphorylation, tumor

Received: November 16, 2016 Accepted: March 28, 2017 Published: April 18, 2017

ABSTRACT

Adducin is a membrane-skeletal protein localized at spectrin-actin junctions, involving in the formation of the network of cytoskeleton, cellular signal transduction, ionic transportation, cell motility and cell proliferation. While previous researches focused mainly on the relationship between adducin and hypertension, there are few studies focusing on the role of adducin in tumor. Previous studies showed that adducin played a role in the evolution and progression of neoplasm. This review makes a brief summary on the structure, function and mechanism of adducin and how adducin functions in tumorigenesis and metastasis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17173

Publication Alerts

Oncoscience

Post-Publication Promotion

Reviews:

Adducin in tumorigenesis and metastasis

Abstract